Stanford's AI agents designed a drug Merck later built, too | VentureBeat
For developers, the operating assumption has been one engineer, one agent — the model Claude Code and similar tools. At VB Transform 2026, James Zou, associate professor of biomedical data science at Stanford University, argued that assumption is about to break: the next frontier isn't a single, more capable agent, it's tens of thousands of them collaborating.
For developers and product builders, the most critical takeaway from Zou’s presentation is how these massive systems are orchestrated. His team's research offers a practical blueprint for connecting legacy databases to AI orchestration layers and designing environments that enable thousands of agents to collaborate.
Emulating the organization — the virtual biotech
Zou’s project began as a "Virtual Lab" consisting of five to eight agents structured to mirror his physical Stanford lab. The setup included an AI professor acting as the principal investigator and AI students with distinct specialties holding regular group meetings.
...
Copyright of this story solely belongs to venturebeat.com. To see the full text click HERE
